User:Manum56/sandbox
Paul Garner | |
|---|---|
 | |
| Born | 25 August 1955 |
| Alma mater | |
| Occupation |
|
Paul Garner is a British epidemiologist and Public Health professional, known for his work in Systematic Reviews and Evidence Informed Policy. He is currently an honorary Professor of evidence synthesis at the Liverpool School of Tropical Medicine. Previously he was a member of the WHO malaria treatment guidelines group from 2004-18.
Early Life, Education and Career
Paul Garner attended Spalding Grammar School in Lincolnshire in the UK. He received an MB BS from University College London in 1979, and MD from the University of London in 1990.
He started his career in as a physician in Papua New Guinea. There he ran the Aitape Health Center in the West Sepik Province 1982-84, a 100 bedded hospital with a catchment area of 200,000 population. He subsequently worked as a researcher at the Institute of Medical Research in Madang between 1984 and 1988.[1]
He was a full time Professor of evidence synthesis at the Liverpool School of Tropical Medicine between 2004 and 2022, where now he serves as an honorary professor and the Director of the Center for Evidence Synthesis in Global Health. He is also an honorary research fellow at St Georges Medical School, Grenada since 1997,and honorary Professor at the University of Stellenbosch since 2013. He also acted as the Director of a series of UK Government research and development programmes in evidence synthesis related to problems of the tropics and low and middle income countries, the most recent being READ-It, 2018-2024.
Notable contributions
In 1992, Paul Garner played a key role in the development of the Cochrane Collaboration after its founding. He led the Cochrane Infectious Diseases Group, whose reviews have helped underpin policy changes across the world.
Paul directly contributed to change in the formulation of Oral re-hydration solution and global policies related to its use in treatment of diarrheal diseases using oral re-hydration therapy. At the time WHO used a 311mOsm/l solution as the standard and the systematic review clearly showed that lower osmolarity of 240mOsm/l is more effective [2][3][4].
Paul has worked closely with the World Health Organization in the development of malaria treatment guidelines from 2004 to 2018, organizing evidence synthesis for the three editions in 2006, 2010, and 2015. He played a key role in the introduction of Artemisinin based combination treatments for malaria around the world[5].
His systematic reviews have also challenged global dogmas, including Directly Observed Therapy for tuberculosis[6], and routine de-worming of soil transmitted helminths in schoolchildren in living in endemic areas in middle and low-income countries[7].
Drawing from personal experience, Paul worked to highlight the occurrence of the post-covid-19 syndrome and health concerns related to it[8][9]. He advocated the involvement of communities of people who have recovered from post-viral illnesses would be helpful in the management and treatment approaches.
References
- ^ "ORCID". orcid.org. Retrieved 2022-08-15.
- ^ Fontaine, Olivier; Garner, Paul; Bhan, M. K. (2007-01-04). "Oral rehydration therapy: the simple solution for saving lives". BMJ. 334 (suppl 1): s14–s14. doi:10.1136/bmj.39044.725949.94. ISSN 0959-8138.
- ^ Hahn, Seokyung; Kim, YaeJean; Garner, Paul (2001-07-14). "Reduced osmolarity oral rehydration solution for treating dehydration due to diarrhoea in children: systematic review". BMJ : British Medical Journal. 323 (7304): 81–85. ISSN 0959-8138. PMID 11451782.
- ^ World Health Organization (2002). "Reduced osmolarity : oral rehydration salts (ORS) formulation : a report from a meeting of experts jointly organised by UNICEF and WHO : UNICEF house, New York, USA, 18 July 2001".
{{cite journal}}: Cite journal requires|journal=(help) - ^ Adjuik, M.; Babiker, A.; Garner, P.; Olliaro, P.; Taylor, W.; White, N.; International Artemisinin Study Group (2004-01-03). "Artesunate combinations for treatment of malaria: meta-analysis". Lancet (London, England). 363 (9402): 9–17. doi:10.1016/s0140-6736(03)15162-8. ISSN 1474-547X. PMID 14723987.
- ^ Volmink, J.; Garner, P. (2007-10-17). "Directly observed therapy for treating tuberculosis". The Cochrane Database of Systematic Reviews (4): CD003343. doi:10.1002/14651858.CD003343.pub3. ISSN 1469-493X. PMID 17943789.
- ^ Taylor-Robinson, David C.; Maayan, Nicola; Donegan, Sarah; Chaplin, Marty; Garner, Paul (2019-09-11). "Public health deworming programmes for soil-transmitted helminths in children living in endemic areas". The Cochrane Database of Systematic Reviews. 9: CD000371. doi:10.1002/14651858.CD000371.pub7. ISSN 1469-493X. PMC 6737502. PMID 31508807.
- ^ Ethiraj, Govindraj (2020-07-21). "A British Epidemiologist's Ongoing Battle With COVID-19". www.boomlive.in. Retrieved 2022-08-15.
- ^ BMJ (2020-05-05). "Paul Garner: For 7 weeks I have been through a roller coaster of ill health, extreme emotions, and utter exhaustion". The BMJ. Retrieved 2022-08-15.